Biogen Appoints Daniel Quirk as Chief Medical Officer and Chief Medical Officer

WESTON (dpa-AFX) – Biogen (BIIB) has appointed Daniel Quirk as Chief Medical Officer and Chief Medical Officer, effective October 28, 2024. Before joining the Biogen team, Quirk was Senior Vice President of Worldwide Medical Affairs for Immunology and Medical Affairs. He worked in Neuroscience at Bristol-Myers Squibb and previously served as Senior Vice President of US Medical Affairs and Vice President of US Medical Affairs for Immunology and Fibrosis at BMS.

“At Biogen, scientific and medical leadership is foundational to everything we do, and that’s why we believe Dan will be an excellent choice to lead our Medical Affairs organization into the future,” said Priya Singhal, President of Biogen Development.

For more Health News like this, visit rttnews.com.